Botulinum Toxin Injection With Prostate Brachytherapy
Status:
Withdrawn
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if botox injection into the prostate during seed
implantation (brachytherapy) for prostate cancer a) improves urinary symptoms or avoids need
for urinary tract instrumentation over the 6-8 month post-operative period when one wants to
avoid manipulating the radioactive seeds, and b) speeds up the drop in PSA. Patients will be
randomized to botox vs saline injection, at the completion of the seed implantation
procedure.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA